Dana Daukss draws on her academic training and professional experience in the life sciences and engineering industries to offer a unique, wide-ranging perspective to clients. In particular, she assists companies in the preparation and prosecution of patent applications, as well as freedom-to-operate analysis and due diligence reviews. Publications and Presentations “Patent watch: Microscale implantable drug delivery systems: emerging IP strategies”, co-author, Nature Reviews Drug Discovery 15.11, 740-741, 2016. “Role of Fas and Treg Cells in Fracture Healing as Characterized in the Fas-Deficient (lpr) Mouse Model of Lupus,” co-author, Journal of Bone and Mineral Research, 29(6), 1478-1491. “Effects of lamprey PQRFamide peptides on brain gonadotropin-releasing hormone concentrations and pituitary gonadotropin-β mRNA expression,” first-author, General and comparative endocrinology, 177(2), 215-219. “Evolutionary origin of the structure and function of gonadotropin-inhibitory hormone: insights from lampreys,” co-author, Endocrinology, 153(5), 2362-2374. Education & Credentials Boston University College of Engineering, ME (2014) Biomedical Engineering University of New Hampshire, BS (2011) summa cum laude Admissions Massachusetts Bar Admission Pending U.S. Patent & Trademark Office